China uses two major mechanisms to negotiate medicine prices, offering manufacturers a route to substantial demand in exchange for terms acceptable to public purchasers and insurers. One organizes ...

Cancer drug developers seeking approval in several countries can bring regulators together through Project Orbis, allowing agencies to discuss the same evidence while retaining responsibility for ...

LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world's largest ...

September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals.

Caribou Biosciences, the off-the-shelf cell therapy outfit that spun out of Nobel Laureate Jennifer Doudna’s lab in 2011, is ...

Recursion Pharmaceuticals Inc. stocks have been trading down by -4.43 percent after AI drug-discovery partnership concerns ...

Cerevance plans to meet with the FDA to determine next steps for a new kind of medicine known as solengepras, now that it has ...

A new generation of Australian life sciences innovation will take the stage on the Gold Coast this month, with AusBiotech ...

Caribou Biosciences, Inc. (CRBU) is down 43.35 percent, losing $0.4920 to $0.6430 on Wednesday. Vaxcyte Prices Offerings Of Stock, Warrants, Convertible Notes To Raise Approx. $1 Bln October 07, 2026 ...

Catalent is vying for a stronger foothold in next-gen drug development, and it's betting on developer's need for speed. | ...

The business provides AI-enabled data intelligence and decision-support tools for R&D and commercialization to the ...

A five-year partnership between CSIRO and Moderna has been unveiled to help develop research to biosecurity threats in ...